Science Unlocks New Frontiers in Health, Environment

News Desk

Islamabad: In a series of groundbreaking studies, researchers have unveiled new insights that could reshape how we manage plastic waste, protect reproductive health, and treat chronic inflammation.

In an innovative step toward sustainable medicine, scientists have discovered a way to turn plastic waste into acetaminophen, the active ingredient in Tylenol. Typically produced from fossil fuels, acetaminophen can now be synthesized using a fermentation process that repurposes polyethylene terephthalate (PET) a common plastic used in water bottles and food packaging.

The method, reported in Nature Chemistry and supported by pharmaceutical giant AstraZeneca, uses genetically engineered bacteria to break down PET and convert it into acetaminophen in under 24 hours at room temperature. Researchers say the process is virtually carbon-neutral.

“This work demonstrates that PET plastic isn’t just waste,” said Stephen Wallace, lead researcher from the University of Edinburgh. “It can be transformed by microorganisms into valuable products that can treat disease.”

Though promising, the method requires further development before it can be scaled for commercial use.

Microplastics Found in Reproductive Fluids

Meanwhile, alarming new findings presented at the European Society of Human Reproduction and Embryology in Paris reveal that microplastics have been detected in human reproductive fluids, raising fresh concerns about fertility and long-term health.

In a small study, microplastic particles were found in the follicular fluid of 69% of women and in the seminal fluid of 55% of men. These fluids play vital roles in natural and assisted conception.

Lead researcher Emilio Gomez-Sanchez of Next Fertility Murcia in Spain warned that microplastics—tiny particles under 5 millimeters in size—may impair reproductive functions. The detected materials included common plastic polymers like Teflon, PET, polystyrene, and polyurethane.

A separate study from Tunisia showed that sperm exposed to microplastics exhibited reduced motility and DNA damage, further underlining the potential reproductive risks.

Breakthrough in Chronic Inflammation Treatment

In another significant development, researchers at Massachusetts General Hospital have identified a protein that can be targeted to turn off chronic inflammation without disrupting the body’s short-term immune responses.

Published in Nature, the study found that the protein WSTF, which regulates inflammatory genes, becomes degraded in conditions such as arthritis, obesity, and fatty liver disease. By restoring WSTF in human cells, scientists were able to halt chronic inflammation without affecting acute responses to infections or injuries.

A new drug developed to preserve WSTF showed positive results in mice with inflammatory conditions and in human knee joint cells from patients undergoing surgery.

“Our findings help us distinguish chronic from acute inflammation and offer a new therapeutic target,” said study leader Zhixun Dou.

These scientific advances mark important strides in converting waste into medicine, understanding the hidden impacts of pollution on fertility, and combating diseases linked to chronic inflammation—all signaling new hope for environmental and human health.